Development and spread of bacterial resistance to antimicrobial agents: An overview

Clinical Infectious Diseases

Volumn 33, Issue SUPPL. 3, 2001, Pages

  Tenover, F C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL MUTATION; CONFERENCE PAPER; GENE TRANSFER; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CLINICAL LABORATORY TECHNIQUES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 0035884894     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321834     Document Type: Conference Paper

References (110)

1. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
2. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit
3. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system
4. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: Emergence of resistance to imipenem
5. Increasing spectrum of resistance in multiresistant Salmonella typhimurium
6. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: Current antibiotic therapy in the 1990s
7. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
8. An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil
9. Control of antimicrobial resistance in the health care system
10. Molecular epidemiology of vancomycin-resistant enterococci: A 2-year perspective
11. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
12. Detection and reporting of organisms producing extended-spectrum β-lactamases: A survey of laboratories in Connecticut
13. Occurrence and detection of extended spectrum β-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center: Seek and you may find
14. Antimicrobial susceptibility testing: General principles and contemporary practices
15. The challenges of emerging infectious diseases: Development and spread of multiply resistant bacterial pathogens
16. Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States
17. The population genetics of antibiotic resistance
18. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing
19. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level
20. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae
21. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in gyrA, parC, and parE loci
22. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals
23. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis
24. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high level resistance to extended spectrum cephalosporins
25. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
26. A functional classification scheme for β-lactamases and its correlation with molecular structure
27. Cloning and sequencing of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli
28. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
29. β-lactamases in the clinical laboratory and clinical resistance
30. Outbreak of ceftazidime resistance caused by extended spectrum β-lactamases at a Massachusetts chronic-care facility
31. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States
32. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993
33. Carbapenem-hydrolyzing β-lactamases
34. Modes of gene transfer in bacteria
35. Genes and their varied hosts
36. Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections
37. Molecular analysis of R factors from multiresistant nosocomial isolates
38. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae
39. A transferable multiple drug resistance plasmid from Vibrio cholerae OI
40. Epidemic Shigella dysenteriae type 1 in Burundi: Pan-resistance and the implications for prevention
41. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: Evidence for conjugative exchange of resistance
42. Conjugative transposons and dissemination of antibiotic resistance in streptococci
43. Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Staphylococcus aureus
44. In vivo transfer of genetic information between gram-negative and gram-positive bacteria
45. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993
46. Dissemination of vancomycin-resistant enterococci in the United States
47. Vancomycin-resistant enterococci: Mechanism and clinical relevance
48. Resistance to glycopeptides in enterococci
49. VanD-type glycopeptide-resistant Enterococcus faecium BM4339
50. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
51. Characterization of glycopeptide-resistant enterococci from U.S. hospitals
52. A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology
53. Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications
54. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
55. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin
56. Spread of vancomycin-resistant enterococci: Differences between the United States and Europe
57. Glycopeptide-resistant enterococci: A decade of experience
58. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands
59. First confirmed case of a vancomycin-resistant Enterococcus faecium with VanA phenotype from Brazil: Isolation from a meningitis case in Sao Paulo
60. Epidemiology of glycopeptide resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa
61. Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates
62. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and clones
63. VanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum
64. vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans
65. Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis
66. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
67. Inactivation of antibiotics and the dissemination of resistance genes
68. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals
69. Historical yearly usage of vancomycin
70. Antimicrobial use in long term care facilities
71. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio
72. Use of antimicrobial agents in animal feeds: Implications for human health
73. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
74. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia
75. Pneumococcal resistance to antibiotics
76. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
77. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
78. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in the United States, 1997-1998
79. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
80. Trends in antimicrobial drug prescribing among office-based physicians in the United States
81. Risk factors for carriage of drug resistant Streptococcus pneumoniae among children in Memphis, Tennessee
82. Emergence of vancomycin resistance in Staphylococcus aureus: Epidemiology and clinical significance
83. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
84. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance
85. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
86. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin
87. Vancomycin-resistant Staphylococcus aureus
88. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital
89. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany
90. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus
91. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50
92. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
93. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates
94. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds
95. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin
96. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected U.S. hospitals
97. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci
98. Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: A report from the College of American Pathologists Microbiology Proficiency Survey Program
99. Ability of laboratories to detect emerging antimicrobial resistance: Proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing
100. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae
101. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s
102. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles
103. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain
104. Recommendations for preventing the spread of vancomycin resistance
105. Interim guidelines for the prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin